Kim-Lien Nguyen1, 2, Sarah N. Khan3, John Moriarty3, Kiyarash Mohajer3, Pierangelo Renella3, Gary Satou4, Swati Patel5, Ines Boechat3, Paul J. Finn3
1Laboratory of Cardiac Energetics, NHLBI, Bethesda, MD, United States; 2Division of Cardiology, David Geffen School of Medicine at UCLA, United States; 3Department of Radiology, David Geffen School of Medicine at UCLA, United States; 4Division of Pediatric Cardiology, David Geffen School of Medicine at UCLA, United States; 5Department of Anesthesiology, David Geffen School of Medicine at UCLA, United States
Widespread adoption of cardiac MR at 3.0T in the clinical setting has been slow. To the best of our knowledge, there have been no published reports on the use of 3.0T for the imaging in pediatric congenital heart disease. Our study demonstrates that cardiac MRI at 3.0T in pediatric patients with congenital heart disease and vascular abnormalities is feasible and compares the technical and diagnostic performance with an age-matched and clinically comparable control group at 1.5 T.